ICMR approves Mylab’s Covid-19 self-testing equipment CoviSelf

The Indian Council of Medical Research (ICMR) on Wednesday authorised the self-use Rapid Antigen Test for Covid-19 developed by Mylab Discovery Solutions. The check is developed in India and is known as as CoviSelf.
The self-use check can be utilized by symptomatic people and quick contacts of confirmed instances as per ICMR tips. Users of this check is not going to want pattern assortment by a healthcare skilled, an official assertion issued immediately has mentioned. Advising towards the indiscriminate use of the kits, ICMR has reiterated that every one symptomatic people who check damaging by RAT ought to get themselves instantly examined by RTPCR

Each equipment shall be supplied with all testing supplies, directions to make use of (IFU) leaflet, and a biohazard bag to securely get rid of it after testing. The check is designed to be finished utilizing a nasal swab (not the deep nasopharyngeal swab) to scale back the discomfort. CoviSelf will present leads to 15 min. Those who check damaging and proceed to expertise COVID-like signs ought to search follow-up care from their healthcare supplier.
The check is priced at Rs 250 and the corporate will begin transport out checks inside just a few days.

“This is the biggest crisis our country has ever faced. CoviSelf will help in saving lives. For India, we will make millions of kits available at fraction of the cost of such kits in the US,” Hasmukh Rawal, Managing Director of Mylab Discovery Solutions mentioned.
“This easy-to-use test combines with Myab’s AI-powered mobile app so that a user can know his/her positive status, submit the result to ICMR directly for traceability, and know what to do next in either case of result. We are sure this small step will be a big leap in mitigating the second and subsequent waves, ” mentioned Sujit Jain, Director at Mylab Discovery Solutions.